Michael Nevradakis, Ph.D., is a senior reporter for The Defender and host of 'The Defender In-Depth' on CHD.TV. Based in Athens, Greece, he covers themes related to law and legal affairs, healthcare administration, and public health, with a focus on litigation and alternative medicine. He has been featured in various outlets, including The Conservative Woman, LifeSiteNews, and The Epoch Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Michael Nevradakis covers a wide range of topics, with a focus on healthcare and pharmaceuticals, government and politics, culture and society. He appears to prioritize articles that include government announcements, legal policy regulations, data citations or expert commentary.
Given his coverage attributes and themes covered, Michael is likely to respond well to pitches from experts in the fields of public health policy or regulatory affairs. Pitches should provide insights into government policies related to healthcare and pharmaceuticals or offer new data analysis relevant to these areas.
It's also important for sources reaching out to Michael to have expertise in addressing societal issues impacted by governmental decisions as they relate to healthcare. This could involve providing unique perspectives on cultural implications of medical developments such as vaccines or surveillance technologies.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Written by Michael Nevradakis, Ph.D. on May 21, 2026 . Posted in Current News
Written by Michael Nevradakis, Ph.D. on May 25, 2026 . Posted in Current News U.S. Health Secretary Robert F.
By: Michael Nevradakis
According to investigative reporter Paul Thacker, the Gates Foundation has donated “hundreds of millions of dollars” to NIH in the last 25 years, allowing the billionaire “to shape the direction of the country's health strategy in ways that have benefitted his own priorities and pet causes while polishing his image as a benevolent global do-gooder.”
By: Michael Nevradakis
According to declassified documents released last week by outgoing Director of National Intelligence Tulsi Gabbard, Many are currently or have previously engaged in research using “hazardous and highly contagious pathogens,” according to a statement. About a third are located in Ukraine and are “vulnerable to longstanding threats of Russian attack, seizure, or damage.”
By: Michael Nevradakis
An inside source with knowledge of Sen. Rand Paul's plans told The Defender on condition of anonymity that Dr. Anthony Fauci is expected next month to testify under oath before the U.S. Senate Committee on Homeland Security & Governmental Affairs about “everything” — from his involvement in funding gain-of-function research that may have created COVID-19 to the subsequent cover-up of a possible lab leak.
By: Michael Nevradakis
The developers of a universal coronavirus vaccine designed by AI are promoting it as a solution to future pandemics. But critics question whether a single vaccine can protect against an entire family of rapidly evolving viruses. They also warn that the vaccine carries the risk of DNA contamination — and likely other unknown risks.
By: Michael Nevradakis
Take a genetically susceptible child, expose that child to mold, and then add an immune trigger — like a vaccine — that “tips an already-strained system over the edge,” and you may create a “three-way collision” that can lead to autism, according to Dr. Christian Bogner.
By: Michael Nevradakis
AstraZeneca can't be held liable for injuries sustained by a woman who participated in the drugmaker's COVID-19 vaccine trial, a federal appeals court ruled last week. However, it will be up to a lower court to decide if the company waived its legal immunity by having trial participants sign a consent form promising the drugmaker would pay participants' medical expenses if the vaccine caused injury or illness.
By: Michael Nevradakis
An April court ruling required Poland and Romania to pay Pfizer about $1.5 billion and $640 million, respectively, plus interest and fees, for additional COVID-19 vaccine doses the countries were obligated to buy under a 2021 contract signed between the European Commission. The countries refused additional vaccine deliveries in 2022, citing falling demand for the shots.
By: Michael Nevradakis
The use of educational technology — from software designed for school and educational settings to school-issued tablets and Chromebooks — increased significantly during the COVID-19 pandemic. But critics, including parents, say that instead of serving as a temporary measure, EdTech has increasingly become a mainstay in the classroom — and it's harming children and the learning process.
